ConductScience.org, home

Paper41377933

mRNA Cancer Vaccines: From Pandemic Paradigm to Personalized Oncology Therapeutics.

Yang B and 3 others. Cancer Innov, 2025. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. mRNA Cancer Vaccines: From Pandemic Paradigm to Personalized Oncology Therapeutics. Papers, record 41377933. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41377933

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
mRNA Cancer Vaccines: From Pandemic Paradigm to Personalized Oncology Therapeutics.
PubMed
Journal
Cancer Innov
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
1.99, provisional
iCite
Revised in PubMed
2026-09-25
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yang BBo
2Liu JJuanhttps://orcid.org/0000-0003-1399-6719
3Li YYang
4Liu XXiaoxuan

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References190

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132728218An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma.Nature2020https://conductscience.org/library/papers/32728218PubMed
234266884Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin.J Immunother Cancer2021https://conductscience.org/library/papers/34266884PubMed
336151112Payload distribution and capacity of mRNA lipid nanoparticles.Nat Commun2022https://conductscience.org/library/papers/36151112PubMed
438142147The potential of mRNA vaccines in cancer nanomedicine and immunotherapy.Trends Immunol2024https://conductscience.org/library/papers/38142147PubMed
535224304Blockading a new NSCLC immunosuppressive target by pluripotent autologous tumor vaccines magnifies sequential immunotherapy.Bioact Mater2022https://conductscience.org/library/papers/35224304PubMed
640336841
O6-methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo, and sensitivity to alisertib-carboplatin combination treatment.
Front Cell Neurosci2025https://conductscience.org/library/papers/40336841PubMed
739849594
WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome.
J Hematol Oncol2025https://conductscience.org/library/papers/39849594PubMed
838890171Expression of the tumor antigens NY-ESO-1, tyrosinase, MAGE-A3, and TPTE in pediatric and adult melanoma: a retrospective case control study.Virchows Arch2024https://conductscience.org/library/papers/38890171PubMed
938715363Development of an mRNA-based therapeutic vaccine mHTV-03E2 for high-risk HPV-related malignancies.Mol Ther2024https://conductscience.org/library/papers/38715363PubMed
1037652091A review on PLGA particles as a sustained drug-delivery system and its effect on the retina.Exp Eye Res2023https://conductscience.org/library/papers/37652091PubMed
1139387241Discovery of Ketal-Ester Ionizable Lipid Nanoparticle with Reduced Hepatotoxicity, Enhanced Spleen Tropism for mRNA Vaccine Delivery.Adv Sci (Weinh)2024https://conductscience.org/library/papers/39387241PubMed
1240348781Proteome-wide determinants of co-translational chaperone binding in bacteria.Nat Commun2025https://conductscience.org/library/papers/40348781PubMed
1340185331Enhancing antitumor immunity through chemotherapeutic-derived lipid nanoparticle-induced immunogenic cell death and CD40L/Flt3L mRNA-mediated dendritic cell activation.J Control Release2025https://conductscience.org/library/papers/40185331PubMed
1439731215Revolutionising Cancer Immunotherapy: Advancements and Prospects in Non-Viral CAR-NK Cell Engineering.Cell Prolif2025https://conductscience.org/library/papers/39731215PubMed
1539737597Transfection Potency of Lipid Nanoparticles Containing mRNA Depends on Relative Loading Levels.ACS Appl Mater Interfaces2025https://conductscience.org/library/papers/39737597PubMed
1637117161Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus.Signal Transduct Target Ther2023https://conductscience.org/library/papers/37117161PubMed
1739798545Clinical advances of mRNA vaccines for cancer immunotherapy.Med2025https://conductscience.org/library/papers/39798545PubMed
1840629076Eliciting antitumor immunity via therapeutic cancer vaccines.Cell Mol Immunol2025https://conductscience.org/library/papers/40629076PubMed
1935595777Codon-specific Ramachandran plots show amino acid backbone conformation depends on identity of the translated codon.Nat Commun2022https://conductscience.org/library/papers/35595777PubMed
2039015802Robust anti-tumor immunity through the integration of targeted lipid nanoparticle-based mRNA nanovaccines with PD-1/PD-L1 blockade.Mater Today Bio2024https://conductscience.org/library/papers/39015802PubMed

See all 190 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42888436The advances and challenges of mRNA-LNP application in fields of hematology and oncology therapeutics.J Hematol Oncol2026https://conductscience.org/library/papers/42888436PubMed
42877411Gene therapy for non-obstructive azoospermia: therapeutic avenues and translational pathway to clinical application.Front Genome Ed2026https://conductscience.org/library/papers/42877411PubMed
42782773mRNA Vaccines as Novel Immunotherapeutic Approaches in Gastrointestinal Cancers.Cells2026https://conductscience.org/library/papers/42782773PubMed
42765443mRNA Therapeutics Beyond Infectious Diseases: Expanding Therapeutic Applications and Future Perspectives.Immun Inflamm Dis2026https://conductscience.org/library/papers/42765443PubMed
42565117Beyond the genetic code: orchestrating epigenetic and immune landscapes with multivalent mRNA-exosome vaccines.Precis Clin Med2026https://conductscience.org/library/papers/42565117PubMed
42482783mRNA cancer vaccines: delivery strategies, immune modulation, and clinical translation.Front Pharmacol2026https://conductscience.org/library/papers/42482783PubMed
42380060Toward the Era of Precision Immunotherapy: The Clinical Landscape and Future Directions of mRNA Vaccines for the Treatment of Hepatocellular Carcinoma.J Gastroenterol Hepatol2026https://conductscience.org/library/papers/42380060PubMed
42174288Preserving the future of vaccine science in the USA.Nat Microbiol2026https://conductscience.org/library/papers/42174288PubMed
42052515Nanotechnology-Assisted Co-Delivery of Immunotherapeutic Agents for Targeting Ovarian Cancer: Prospects and Challenges.Int J Nanomedicine2026https://conductscience.org/library/papers/42052515PubMed
41971684mRNA vaccines in oncology: personalized cancer immunization and neoantigen targeting.Mol Cell Oncol2026https://conductscience.org/library/papers/41971684PubMed
41893758Circular RNA as a New Vaccine Platform: Considerations, Challenges, and Perspectives.Vaccines (Basel)2026https://conductscience.org/library/papers/41893758PubMed
41377933mRNA Cancer Vaccines: From Pandemic Paradigm to Personalized Oncology Therapeutics.Cancer Innov2025https://conductscience.org/library/papers/41377933PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41377933

GET https://conductscience.org/api/papers/v1/41377933/references?page=2